Skip to main navigation Skip to search Skip to main content

AZ CLL QoL: Medical Events of Interest and Health-Related Quality of life in Chronic Lymphocytic Leukemia Patients Initiating Treatment with Bruton's Tyrosine Kinase Inhibitors Acalabrutinib or Ibrutinib

Project: Research

Project Details

StatusFinished
Effective start/end date01/14/22 → 12/31/25

Funding

  • Adelphi Group: $9,520.00